Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 90100 in Psoriasis Vulgaris
NCT01536938Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- May 2012
- Primary completion
- Sep 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcipotriol in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started May 2012; status: completed.
02
Drugs
calcipotriol
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT01536938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536938.